S Faiz - Academia.edu (original) (raw)
Papers by S Faiz
European Journal of Clinical Microbiology & Infectious Diseases, 2008
This is an economic evaluation that meets the criteria for inclusion on NHS EED.
European Journal of Clinical Microbiology & Infectious Diseases, 2008
This is an economic evaluation that meets the criteria for inclusion on NHS EED.
CHEST Journal, 2006
joint pains, fever, weight loss, chest pain, cough, hemoptysis, muscle weakness, tenderness, ting... more joint pains, fever, weight loss, chest pain, cough, hemoptysis, muscle weakness, tenderness, tingling or numbness, skin changes, night sweats or swollen lymph nodes. Her vital signs were stable. Her BMI was 39. She had bilateral inspiratory rales and no cyanosis, clubbing or edema.She had a Forced Expiratory Volume in 1 second (FEV1) of 1.54 liters (52% of predicted), a Forced Vital Capacity (FVC) of 1.72 liters (47% of predicted), an FEV1/FVC of 89.6 (110% of predicted) and diffusion capacity of 24.3% predicted. There was no pulmonary hypertension by echocardiogram. Except for mildly elevated Homocysteine, Antithrombin III and Antinuclear Antibody (ANA), the hypercoagulable and serological work up was negative. Purified Protein Derivative (PPD) skin testing was negative. A computed tomogram of the chest revealed mild basal atelectasis with linear fibrosis and non-specific mediastinal adenopathy. An open lung biopsy was performed. The pathology showed mild interstitial expansion with loosely formed granulomas within the alveolar interstitial spaces and in a bronchocentric and perivascular distribution. In addition,
European Journal of Clinical Microbiology & Infectious Diseases, 2008
This is an economic evaluation that meets the criteria for inclusion on NHS EED.
European Journal of Clinical Microbiology & Infectious Diseases, 2008
This is an economic evaluation that meets the criteria for inclusion on NHS EED.
CHEST Journal, 2006
joint pains, fever, weight loss, chest pain, cough, hemoptysis, muscle weakness, tenderness, ting... more joint pains, fever, weight loss, chest pain, cough, hemoptysis, muscle weakness, tenderness, tingling or numbness, skin changes, night sweats or swollen lymph nodes. Her vital signs were stable. Her BMI was 39. She had bilateral inspiratory rales and no cyanosis, clubbing or edema.She had a Forced Expiratory Volume in 1 second (FEV1) of 1.54 liters (52% of predicted), a Forced Vital Capacity (FVC) of 1.72 liters (47% of predicted), an FEV1/FVC of 89.6 (110% of predicted) and diffusion capacity of 24.3% predicted. There was no pulmonary hypertension by echocardiogram. Except for mildly elevated Homocysteine, Antithrombin III and Antinuclear Antibody (ANA), the hypercoagulable and serological work up was negative. Purified Protein Derivative (PPD) skin testing was negative. A computed tomogram of the chest revealed mild basal atelectasis with linear fibrosis and non-specific mediastinal adenopathy. An open lung biopsy was performed. The pathology showed mild interstitial expansion with loosely formed granulomas within the alveolar interstitial spaces and in a bronchocentric and perivascular distribution. In addition,